We are live on ! Find out more
TCM

Towercrest Capital Management Portfolio holdings

AUM $642M
1-Year Est. Return 11.71%
This Fund
S&P 500
This Quarter Est. Return
+13.17%
1 Year Est. Return
+11.71%
3 Year Est. Return
+31.42%
5 Year Est. Return
+23.73%
10 Year Est. Return
+78.8%
AUM
$382M
AUM Growth
+$49.2M
Cap. Flow
+$9.66M
Cap. Flow %
2.53%
Top 10 Hldgs %
47.13%
Holding
85
New
7
Increased
40
Reduced
25
Closed
8

Sector Composition

Rank Sector Weight
1 Technology 2.11%
2 Financials 1.01%
3 Communication Services 0.79%
4 Healthcare 0.52%
5 Consumer Discretionary 0.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPIB icon
26
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
$11.5B
$6.1M 1.59%
166,923
+25,104
+18% +$893K
AAPL icon
27
Apple
AAPL
$4.9T
$6.07M 1.59%
66,584
-860
-1% -$66.6K
SHYG icon
28
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
$7.61B
$5.82M 1.52%
135,630
+6,854
+5% +$290K
SCHB icon
29
Schwab US Broad Market ETF
SCHB
$43B
$5.78M 1.51%
471,630
-64,326
-12% -$742K
IJR icon
30
iShares Core S&P Small-Cap ETF
IJR
$110B
$5.65M 1.48%
82,721
+17,471
+27% +$1.1M
SPEM icon
31
State Street SPDR Portfolio Emerging Markets ETF
SPEM
$17.1B
$4.95M 1.3%
148,032
+20,345
+16% +$636K
ITOT icon
32
iShares Core S&P Total US Stock Market ETF
ITOT
$93.8B
$4.83M 1.26%
69,498
-12,962
-16% -$847K
SPMD icon
33
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
$18.3B
$2.3M 0.6%
73,560
+15,419
+27% +$450K
SCHO icon
34
Schwab Short-Term US Treasury ETF
SCHO
$12.8B
$2.03M 0.53%
78,528
+47,474
+153% +$1.23M
IBB icon
35
iShares Biotechnology ETF
IBB
$9.52B
$2M 0.52%
14,618
-1,000
-6% -$127K
SPSM icon
36
State Street SPDR Portfolio S&P 600 Small Cap ETF
SPSM
$17.1B
$1.88M 0.49%
70,791
+17,148
+32% +$421K
SHY icon
37
iShares 1-3 Year Treasury Bond ETF
SHY
$25.5B
$1.74M 0.45%
20,047
+12,047
+151% +$1.04M
MSFT icon
38
Microsoft
MSFT
$3.35T
$1.73M 0.45%
8,476
-378
-4% -$68.6K
SPTM icon
39
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$13.5B
$1.53M 0.4%
40,480
-5,559
-12% -$199K
META icon
40
Meta Platforms (Facebook)
META
$1.37T
$1.43M 0.37%
6,274
IWF icon
41
iShares Russell 1000 Growth ETF
IWF
$120B
$1.41M 0.37%
29,456
+1,632
+6% +$71.9K
JPM icon
42
JPMorgan Chase
JPM
$933B
$1.3M 0.34%
13,854
-500
-3% -$47.4K
SCHG icon
43
Schwab US Large-Cap Growth ETF
SCHG
$59.1B
$1.3M 0.34%
102,504
-424
-0.4% -$4.94K
SCHD icon
44
Schwab US Dividend Equity ETF
SCHD
$103B
$1.21M 0.32%
70,389
-159,528
-69% -$2.69M
AIG icon
45
American International
AIG
$41.8B
$1.07M 0.28%
34,438
+2,290
+7% +$64.3K
T icon
46
AT&T
T
$159B
$915K 0.24%
40,087
-4,565
-10% -$104K
JNJ icon
47
Johnson & Johnson
JNJ
$617B
$715K 0.19%
5,081
+1
+0% +$146
MRK icon
48
Merck
MRK
$321B
$714K 0.19%
9,672
DGRO icon
49
iShares Core Dividend Growth ETF
DGRO
$42.8B
$680K 0.18%
18,086
-59,552
-77% -$2.17M
BRK.B icon
50
Berkshire Hathaway Class B
BRK.B
$1.1T
$612K 0.16%
3,429
+1,578
+85% +$288K

Similar funds

Towercrest Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, Towercrest Capital Management held 85 positions worth $382M, up 15% from $333M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Towercrest Capital Management's Q2 2020 filing shows 7 new, 40 increased, 25 reduced and 8 closed positions. Its largest new stake was Restaurant Brands International: 35,300 shares worth $268K. The largest sale was State Street SPDR Bloomberg Investment Grade Floating Rate ETF, an estimated $3.82M.

By sector, the portfolio is most concentrated in Technology at 2.1% of assets, up from 1.8% a quarter earlier, followed by Financials and Communication Services.

  • Towercrest Capital Management's largest Q2 2020 buy was Restaurant Brands International: 35,300 shares worth $268K.
  • Towercrest Capital Management added most to Schwab US Large- Cap ETF in Q2 2020, an estimated $2.77M increase.
  • Towercrest Capital Management's biggest Q2 2020 reduction was State Street SPDR Bloomberg Investment Grade Floating Rate ETF, cutting an estimated $3.82M.
  • Towercrest Capital Management fully exited Iovance Biotherapeutics in Q2 2020, selling an estimated $748K.
  • Towercrest Capital Management's ten largest holdings make up 47% of its $382M portfolio in Q2 2020.
  • Towercrest Capital Management opened 7 new positions and closed 8 in Q2 2020.
  • Towercrest Capital Management's portfolio value rose 15% quarter-over-quarter to $382M.

Based on Towercrest Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.